Is Galectin Therapeutics Inc. (NASDAQ:GALT) Worth A Bite? GALT 200 SMA stands at 19.09%
Galectin Therapeutics Inc. (NASDAQ:GALT) previous close was $3.49 while the outstanding shares total 57.13M. The firm has a beta of 2.35. GALT’s shares traded lower